Dosidal · Switzerland

Lescol Retard, Retardtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:55489 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 55489
atc: C10AA04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2000-08-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: C10AA04
authorisation_number: 55489
form: RETT
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 07.12.0.
name: Lescol Retard, Retardtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
NxyMnBOSS8q3X5kZaQ071NLZ0ejpbL1V7H4TELv3t2VeIJx3P7Q69WihuMXNYlSppPp6nLk_TsgkrWHYRizuxg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:55489 · Related records in other markets · Dosidal